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Abstract.  Binding of GTP induces ot subunits of het- 
erotrimeric G proteins to take on an active confor- 
mation,  capable of regulating effector molecules. We 
expressed epitope-tagged versions of the ct subunit (txs) 
of Gs in genetically us-deficient $49 cyc- cells. Addi- 
tion of a hemagglutinin  (HA) epitope did not alter the 
ability of wild type t~s to mediate hormonal stimula- 
tion of adenylyl cyclase or to attach to cell mem- 
branes.  The HA epitope did,  however, allow a  mAb to 
immunoprecipitate the recombinant protein (HA-o~) 
quantitatively from cell extracts. We activated the 
epitope-tagged t~ in intact cells by: (a) exposure of 
cells to cholera toxin,  which activates ot~ by covalent 
modification;  (b) mutational  replacement of arginine- 
201  in HA-ct~ by a cysteine residue, to create HA-ct~- 
R201C; like the cholera toxin-catalyzed modification, 
this mutation activates c~ by slowing its intrinsic 
GTPase activity; and (c) treatment of cells with the 
~-adrenoceptor agonist,  isoproterenol,  which promotes 
binding of GTP to ets, thereby activating adenylyl cy- 
clase. Both cholera toxin and the R201C mutation ac- 
celerated the rate of degradation of as (0.03 h -1) by 
three- to fourfold and induced a partial  shift of the 
protein from a membrane bound to a soluble compart- 
ment.  At steady state,  80%  of HA-o~c R201C was 
found in the soluble fraction,  as compared to  10%  of 
wild type HA-ors. Isoproterenol rapidly (in <2 min) 
caused 20% of HA-o~s to shift from the mem- 
brane-bound to the soluble compartment.  Cholera 
toxin induced a  3.5-fold increase in the rate of degra- 
dation of a  second mutant,  HA-c~,-G226A,  but did not 
cause it to move into the soluble fraction; this obser- 
vation shows that loss of membrane attachment is not 
responsible for the accelerated degradation of o~ in re- 
sponse to activation.  Taken together,  these findings 
show that activation of or, induces a conformational 
change that loosens its attachment to membranes and 
increases its degradation rate. 
H 
ETEROTRIM~RIC G proteins transduce signals  from 
cell-surface receptors to membrane-bound etfector 
molecules,  including  adenyly  cyclase,  phospholi- 
pase C, and ion channels (2, 8, 32). Agonist-bound receptors 
activate G proteins by promoting exchange of GTP for GDP 
bound to the ct subunit of the heterotrimer,  ot-GTP rapidly 
dissociates from the ~3' complex and can interact  with the 
effector until its intrinsic  GTPase converts it to ot-GDP, al- 
lowing re-association  with ~3'. Experirnents  in broken cells, 
confirmed and refined in studies  using biochemically pure 
components, show that the nucleotide-bound state of the ot 
subunit determines its interactions  with other proteins. 
How do changes in the active state of G protein o~ subunits 
affect their behavior in the more complex environment  of an 
intact  cell? Attempts  to answer this  question require ex- 
perimental models that allow manipulation of  the nucleotide- 
bound state of intracellular  c~ subunits  and assessments of 
their number, subcellular distribution,  turnover, and associa- 
tions with other proteins.  Here we report an attempt to de- 
vise and exploit such a model. 
The model focuses on the behavior of the o~ subunit (cts)  ~ 
of G,  a  well-characterized  G  protein  that  mediates  hor- 
monal stimulation  of cAMP synthesis by membrane-bound 
adenyly cyclase. A key element of the model, the genetically 
acdeficient cyc- $49 mouse lymphoma cell (3, 13) provides 
a null background for analyzing the behavior of recombinant 
as,  normal  or mutant;  the  nucleotide-bound state of the 
recombinant  c~s can be readily  altered  by /3-adrenoceptor 
(~-AR)  stimulation  and  by cholera  toxin-catalyzed ADP- 
ribosylation.  Two ot~ mutations provide independent  ways 
of manipulating  the protein's  activity: replacement by cys- 
teine of the arginine  residue at position 201 of ors activates 
the protein by reducing  its GTPase activity,  as shown by 
studies of the oncogenic R201C mutation in human pituitary 
adenomas (17); R201 is also the residue covalently modified 
1, Abbreviations used in this paper: u~, ot subunit of stimulatory G pro- 
tein;/3AR,/3 adrene~ic receptor; CTX, cholera toxin; GTP~S, guanosine 
5'-(v-thio)-triphosphate; HA, hemagglutinin; RIPA, radioimmunoprecipi- 
tation assay. 
￿9  The Rockefeller University Press, 0021-9525192/12/1297/11  $2.00 
The Journal of Cell Biology, Volume 119, Number 5, December 1992 1297-1307  1297 by cholera toxin (17, 34). Another mutation, which replaces 
glycine-226 with alanine, prevents Gs from mediating stim- 
ulation  of  cAMP  synthesis  by  cholera  toxin  and  /3-AR 
agonists (4, 22, 30),  apparently because as-G226A  cannot 
readily dissociate from 3"g (18). 
A  lack of suitable antibodies has  slowed experimental 
studies of c~ subunit proteins in intact cells. An ideal anti- 
body for such a purpose would specifically and quantita- 
tively immunoprecipitate the native, undenatured c~ subunit. 
Because none of the polyclonal anti-a~ antisera available  to 
us met this stringent criterion, we adopted an alternative ap- 
proach, which should prove applicable to any G protein ct 
subunit. We tagged recombinant ot~ with a peptide epitope, 
derived from the hemagglutinin (HA) protein of influenza vi- 
rus (11), which is the target of a high-affinity mAh. 
The resulting experimental model, using epitope-tagged 
o~s expressed  in the  $49  cyc- cell,  reveals  that activating 
mutations, like cholera toxin-catalyzed ADP-ribosylation, 
produce two changes  in  the  intracellular behavior of c~s: 
Much of the protein redistributes from a membrane bound 
into a soluble compartment, and its rate of degradation in- 
creases. The first of these changes does not cause the second. 
Materials and Methods 
Materials 
Cholera toxin was obtained from List Biologicals.  [35S]methionine/cys- 
teine (TranaSSlabel) was obtained from ICN Radiochemicals (Irvine, CA). 
Radioactive ATP and cAMP were from DuPont NEN. 125I-labeled protein 
A was from Amersham Corp. (Arlington Heights, IL). All other reagents 
were purchased from Sigma Chemical Co. (St. Louis, MO). 
Construction of  Expression Vectors 
The normal rat as eDNA was available in the pMV7 vector as described 
(33). Mutagenesis was carded out using the Bio-Rad Mutagene kit accord- 
ing to the manufacturer's instructions (Bio-Rad Laboratories, Cambridge, 
MA). Briefly, the as eDNA was ligated into the pTZ vector for production 
of phagemid.  Single-stranded (coding) DNA was annealed to a  41-base 
oligomer containing the information (noncoding strand, 5' CCATCGCTG- 
TTGGACGCGTAATCC~CGTCCTCTTCGCC  3') for the hemaggluti- 
nin epitope (see Fig.  1) flanked on both sides by 12 bases of wild type as 
sequence. An identifying MluI restriction site was also included. The reac- 
tion product was used to transform E.  coli MVll90, and the mutagenized 
eDNA (HA-t~s) derived from an ampicillin-resistant colony was re-ligated 
back into pMV7 for transfection into $49 cells. To create HA-as-R201C, 
a 5' SalI-EcoRI restriction fragment from HA-txs was ligated to an EcoRI- 
AflU fragment  from a  rat  as  eDNA  encoding the  R201C  substitution 
(provided by C. Landis; see reference 17). The resulting SalI-AflII fragment 
was re-ligated into pMV7. HA-as-G226A was generated by ligating the 5' 
HindUI-EcoRI fragment from the HA-as eDNA to the 3' EcoRI-HindIII 
fragment from an as eDNA encoding the G226A substitution (22). eDNA 
constructs were expressed in $49 cyc- cells via packaging cell lines, as de- 
scribed (33). 
Antibodies 
The  mAb  12CA5  (generously provided by Dr.  Ian Wilson) was  raised 
against a  13 amino acid peptide sequence derived from the HA protein of 
influenza virus (11). The antibody was purified from aseites using a BioRad 
Affi-gel protein A column. The column eluate was dialyzed against several 
changes of coupling buffer (0.5  M NaCI, 0.1 M NaHCO3,  pH 8.3),  then 
coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Pis- 
cataway, NJ) according to the manufacturer's directions. Normal mouse as- 
cites (Sigma Chemical Co.) was used as a source of control antibody. For 
immunoblotting, affinity-purified rabbit polyclonal antisera raised against 
residues 27-41 of the wild type txs sequence was used at a concentration of 
10/~g/mi, as described (5). 
Quantitation Standard 
A recombinant fragment of HA-as was used as an immunoblot standard in 
quantitation  studies.  For  its preparation,  the cDNA  encoding residues 
7%213  of HA-as was expressed in E.  coli and purified to homogeneity 
using conventional chromatography. The polypeptide was the generous gift 
of Dr. David Markby (manuscript in preparation). 
Cell Culture and Metabolic Labeling 
The wild type and cyc- $49 cell lines used in this paper were originally 
designated 24.3.2 and 94.15.1, respectively (3). An additional cell line, 3E, 
was generated (33)  by transfecting 94.15.1  cells with the normal rat  Us 
eDNA by the method described above. Cells were maintained under 5% 
CO2 in DME supplemented with 10%  heat-inactivated horse serum. For 
metabolic labeling, cells (at  107/ml) were starved for 3 h in methionine- 
and  cysteine-free DME  with  10%  dialyzed horse  serum.  [3SS]methio- 
nine/cysteine (Tran35Slabel,  1,200  Ci/mmol;  ICN  Radiochemicals) was 
then added, at 250 #Ci/ml. Cells were pulse-labeled for 20 rain and then 
pelleted at 200 g and resuspended in chase medium (DME/horse serum 
supplemented with 1 mM each cold methionine and cysteine). The pulse- 
labeled ceils were divided into  equal  aliquots and incubated (3  x  105 
cells/ml) in chase medium in T75 culture flasks at 37~  5% CO2.  After 
pulse labeling, the cells continued to divide normally. For each time point 
of a turnover analysis, all cells from a given flask (in 50 ml medium) were 
harvested. 
Turnover Studies 
Whole-ceU detergent extracts of metabolically labeled ceils were prepared 
by pelleting cells (typically 20  x  106 per sample) at 200 g, washing once 
with ice-cold PBS, and then lysing in 0.5 ml RIPA buffer (1% NP-40, 0.5% 
Na deoxycholate, 50  mM Tris-HC1,  pH  7.4,  150  mM NaC1,  2.5  mM 
MgC12, 1 mM EDTA, 1 mM DTT, 8 t~g/ml PMSE 2/zg/mi each leupeptin 
and aprotinin) on ice for 1 h. The mixture was then centrifuged at 14,000 
rpm in an Eppendorf centrifuge (Brinkman Instruments Inc., Westhury, 
NY) for 5 rain. The clarified supernatant was used as the whole-cell lysate, 
while the pellet (mostly nuclei, and containing no immunodetectable as) 
was discarded. Metabolically labeled extracts were first pre-cleared by tum- 
bling end-over-end at 4 ~ C for 2 h with 20-#1 vol sephamse beads coupled 
to normal mouse ascites. Pre-clearing beads were pelleted from the extract 
in a microfuge, then 20-/A vol beads coupled to antibody 12CA5 were added 
to each sample. After each sample was tumbled end-over-end overnight at 
4 ~ C, the beads were pelleted, washed twice with RIPA adjusted to 0.3% 
SDS, and once with 0.1% NP-40,  10 mM Tris-HCl, pH 7.4. The beads were 
then suspended in 80 #1 gel sample buffer (125 mM Tris-HCl, pH 6.8, 15% 
sucrose, 2% SDS, 50 mM DTT,  0.01% Bromphenol blue), boiled 5 min, 
and subjected to SDS-PAGE. This was performed as described by Laemmli 
(16), using 10% acrylamide gels. Following electrophoresis, gels were fixed 
and stained in 50%  methanol,  10%  acetic acid,  0.1%  Coomassie blue, 
soaked in Amplify (Amersham Corp.) for 20 rain, dried, and subjected to 
autoradiography at -70  ~ C. The band corresponding to HA-as was excised 
and radioactivity was quantitated by liquid scintillation spectroscopy. 
Cell Fractionation 
For analysis of subcellular distribution of as, cells were allowed to swell 
in hypotonic dounce buffer (20 mM Hepes, pH 7.4,  20 mM KCI, 2.5 mM 
MgCl2, 1 mM EDTA, 1 mM DTT, plus protease inhibitors) for 10 min on 
ice. Samples were then dounce-homogenized using a Wheaton 1-ml tissue 
grinder (>90% cell disruption by light microscopy), and centrifuged for 30 
rain at  150,000  g  in a TL-100 tabletop ultracentrifuge (Beckman Instru- 
ments). The supernatant ($150) fraction was adjusted to 1% NP-40, 0.5% 
Na deoxycholate, 150 mM NaC1,  while the pellet (P150)  was first resus- 
pended in dounce buffer and then likewise adjusted with detergent and NaCl 
and incubated on ice for 45 rain. Detergent-insoluble  material from the P150 
extract was removed by centrifugation in a  microfuge (Beckman Instru- 
ments) at 14,000  rpm for 5 rain. Immunoprecipitation was carded out as 
described above. 
Preparation of  Membranes and Adenylyl 
Cyclase Assay 
For adenylyl cyclase assays, membranes were prepared by nitrogen cavita- 
tion of $49 cells, as described (28). In cell fractionation studies, cells were 
lysed by douncing in the hypotonic buffer described above, then cemrifuged 
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was then centrifuged for 30  min at  150,000  g  to pellet the membranes. 
Adenylyl cyclase activity was measured by the method of Salomon et al. 
(29), with small modifications (5). 
Western Blotting 
Immunoblot analysis was carried out as described by Chang and Bourne (5), 
except for quantitation studies, in which proteins were electroblotted at low 
voltage (25 V) overnight to 0.2 #m pore-sized PVDF membrane (Bio-Rad 
Laboratories). Using these conditions, we obtained a uniform transfer of 
proteins ranging in size from 14 to 46 kD, as assessed by quantitating trans- 
fer and retention of 14C-labeled  molecular weight standards (Amersham 
Corp.). Densitometry was performed using an Ultroscan XL (LKB Instru- 
ments Inc., Bromma, Sweden) on films that had been "preflashed" before 
exposure to the probed membrane. 
Results 
Construction and Expression of  Epitope-tagged t~, 
Alternative splicing of o~, transcripts produces a, proteins 
that migrate at rates corresponding to 45- and 52-kD; com- 
pared to the 45-kD form, the 52-kD form contains a  14- 
amino acid insert (27). No substantial difference in function 
of the two forms has been detected (10). We modified the 52- 
kD form at a site (residues 77-81) within the insert to confer 
upon it recognition by a  mAb,  12CA5,  which is  directed 
against a well-defined (14) peptide epitope of the influenza 
HA (Fig.  1). Alteration of five residues of wild type or, se- 
quence generates a  unique epitope "tag" in the c~ subunit 
(Fig.  1). 
If HA-tagged tx, is  to  serve as  a  valid stand-in  for un- 
tagged o~,, the two types of protein should be expressed in 
similar amounts and distributed similarly in subcellular frac- 
tions;  they should also function similarly as regulators of 
adenylyl cyclase and should be similarly affected by muta- 
tions. 
Tagged and untagged ct, proteins were expressed in simi- 
lar amounts in $49 cells (Fig. 2). A Western blot of mem- 
brane proteins (Fig.  2 A), probed with an afffinity-purified 
anti-o~, antiserum, shows that epitope-tagged a, (lane 3) is 
expressed in cyc- cells at a level comparable to that of the 
52-kD  form of a,  in  wild  type  $49  cells  (lane  /).  The 
tagged ~ subunit migrates slower than its untagged counter- 
part, probably owing to the addition of a negative charge. 
Two mutant forms of o~,, containing the R201C  of G226A 
mutations, were also epitope-tagged and expressed in cyc- 
cells (Fig.  2  A,  lanes 4  and 5,  respectively). The low ex- 
pression of the cecR201C  protein in membranes has been 
observed previously, both in transfected cyc- cells and  in 
pituitary  adenomas  (L.  VaUar, personal communication). 
Epitope-tagged a, is hereafter referred to as HA-o~.  Cyc- 
cells expressing the different tagged o~, constructs are desig- 
nated as HA cells (wild type ct3, HARC cells (R201C),  or 
HAGA (G226A) cells. 
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Rgure 1. c~s vs. HA-us. Amino 
acid residues 76-82 in HA-as 
comprise  the  hemagglutinin 
epitope  for monoclonal anti- 
body  12CA5. Vertical lines 
identify  residues  that  differ 
between normal  as  (52-kDt~ 
form) and HA-a~. 
Figure 2. Western blot analy- 
sis  of $49  clones.  (A) Wild 
type  $49  (24.3.2) and  cyc- 
(94.15.1) ceils  are  compared 
to clones generated by trans- 
fecting cyc- cells with cDNAs 
encoding  HA-as,  HA-as- 
R201C,  and  HA-a,-G226A 
(HA, HARC, and HAGA cells, 
respectively).  Membranes 
were harvested from $49 cells 
by nitrogen cavitation. 50 #g 
of  membrane  protein  from 
each cell line was electropho- 
resed,  transferred  to  nitro- 
cellulose, and probed with a 
rabbit  anti-peptide  antibody 
specific for c~s. The antibody 
probe  was  visualized  with 
~2SI-labeled protein A and au- 
toradiography (24-h exposure). (B) Membrane-bound vs. soluble 
~,.  Cells were harvested by centrifugation at 200 g, resuspended 
in ice-cold hypotonic buffer, and lysed by dounce homogenization 
(see Materials and Methods). The post-nuclear supernatant was 
centrifuged at 15,000 g. 50-#g protein from the pellet (P) and su- 
pernatant (S) fractions of  wild type (24.3.2) and HA cells were ana- 
lyzed by SDS-PAGE and Western blotting, exactly as in A. 
Fig.  2  B  compares membrane-bound (P150) vs.  soluble 
(S150)  ors, with and without the epitope tag, as detected in 
immunoblots probed with an anti-or, antiserum. The distri- 
bution of HA-et, between P150 and S150 fractions is identi- 
cal to that of untagged a,, suggesting that the epitope does 
not disturb targeting of the protein to the plasma membrane. 
This experiment does not accurately reflect the true ratio of 
membrane bound to  soluble cts, however; this  is because 
the immunoblots compare equal quantities of membrane and 
soluble protein, despite the fact that the cells are quite un- 
likely to contain equal amounts of membrane and soluble 
protein. Quantitative immunoprecipitation provides a better 
way of assessing distribution of as between particulate and 
soluble fractions (see below). 
The epitope tag did not alter regulation of adenylyl cyclase 
(Fig. 3). Isoproterenol, GTPTS  , forskolin, and cholera toxin 
increased  adenylyl cyclase in  membranes  from HA  cells 
(Fig. 3 B) in a  fashion indistinguishable from that seen in 
membranes of 3E cells (Fig.  3 A),  which express recom- 
binant wild type t~s lacking the epitope tag.  Adenylyl cy- 
clase in membranes from HAGA or HARC  cells was un- 
responsive to all stimuli or constitutively active, respectively 
(Fig.  3,  C and D); this is exactly the behavior expected of 
or, with the G226A (22) and R201C (17) mutations, suggest- 
ing that the epitope does not substantially alter function of 
either mutant. 
Thus,  assays  of  subcellular  distribution  and  signaling 
function show that  the epitope tag  does not  substantially 
affect normal or mutant c~s. 
Immunoprecipitation and Quantitation of Tagged ~, 
We  used  immunoprecipitates  from metabolically labeled 
cells to compare turnover of epitope-tagged normal and mu- 
Levis and Bourne Epitope-tagged G~s  1299 Figure 3.  Adenylyl cyclase stimulated by  normal  and  epitope- 
tagged ors. Adenylyl cyclase activities were measured  in mem- 
branes prepared from 3E cells, generated (33) by transfecting cyc- 
ceils with wild-type, non-epitope-tagged as (A) and HA, HAGA, 
and HARC cells (B-D, respectively). Conditions were as follows: 
10 #M GTP; 10 #M GTP +  10 #M isoproterenol (ISO); 100 #M 
GTP3,S; 10 #g/ml cholera toxin +  100 #M NAD  + (30 min treat- 
ment); 10 #M forskolin. Values  represent the means + SD of  tripli- 
cate determinations. 
tant ct,. Validity of such comparisons requires quantitative 
extraction and immunoprecipitation of  the protein. Using the 
detergent buffer described in  Materials  and  Methods,  we 
were able to render soluble >95 % of the HA-ot~ in HA cells 
(determined by Western  blot  and  densitometry,  data  not 
shown). Fig. 4 A shows immunoblots of HA-ot~ in a whole- 
cell detergent extract of HA cells (lane/) and in pellet and 
supematant  fractions  produced  by  immunoprecipitation 
(lanes 2 and 3, respectively); immunoblots were probed with 
polyclonal anti-c~  (see Materials and Methods). Densitom- 
etry of these immunoblots showed that >95 % of the HA-o~ 
present in the extract is immunoprecipitated by the 12CA5 
mAb. Fig. 4 B demonstrates specificity of the immunopre- 
cipitation from metabolically labeled cells; the 12CA5 anti- 
body immunoprecipitates HA-c~  from HA cells (lane 2), 
but not from cyc- cells (lane/). 
As a standard for immunoblot determination of the molar 
amount of HA-c~ in HA cells, we used a recombinant frag- 
ment of HA-c~ that contained the epitope and was readily 
available  in  the laboratory (see Materials  and  Methods). 
Known quantities of the recombinant standard were electro- 
phoresed in lanes adjacent to lanes containing HA-ors that 
was immunoprecipitated with the  12CA5  antibody from a 
detergent extract of 107 HA cells.  The proteins were elec- 
troblotted to PVDF membrane and probed with the 12CA5 
antibody (Fig.  5).  Densitometry of the autoradiograph in 
Fig. 5 indicated that 107 HA cells contain 3.97 +  0.47 pmol 
HA-ot~. Accordingly,  each  cell  should  contain  ,0240,000 
HA-o~ molecules. A similar assay showed that a membrane 
Figure 4. Quantitative immunoprecipitation and metabolic labeling 
of HA-c~s. (A) 107 HA cells were extracted in RIPA buffer. 10% of 
this extract was retained as "pre-IP" (lane 1 ). The remainder was 
subjected to immunoprecipitation with 12CA5-coupled  sepharose 
beads. 10% of  both the immunoprecipitation pellet (lane 2) and su- 
pematant  (lane 3) fractions along with the "pre-IP" sample were 
subjected  to  SDS-PAGE,  electroblotted  to  nitrocellulose  and 
probed with an cry-specific  anti-peptide polyclonal antibody, fol- 
lowed by 125I-labeled  protein A. (B) Metabolic labeling. 2  x  107 
HA cells (lane 2) or cyc- cells (lane 1 ) were starved for 3 h in me- 
thionine cysteine-free DME +  10% dialyzed horse serum, then in- 
cubated for 20 min in the same medium containing 250 #Ci per ml 
35S-labeled methionine/cysteine. The  cells  were  then  pelleted, 
washed once in ice-cold PBS, and lysed in 0.5 ml RIPA buffer. The 
clarified, pre-cleared extracts were then subjected to immunopre- 
cipitation with 12CA5-coupled sepharose beads and SDS-PAGE. 
The gel was soaked for 20 min in Amplify and analyzed by autora- 
diography (12-h exposure). 
preparation from HA cells (prepared by nitrogen cavitation, 
as detailed in Materials and Methods) contained 16.6 +  2.0 
pmol HA-ors per mg protein (n  =  3). 
The 12CA5 antibody did not co-immunoprecipitate G pro- 
tein  13  subtmit  with  HA-ors, as  assessed  by probing  im- 
munoprecipitates with an anti-13 antiserum; in addition, im- 
munoprecipitates from metabolically labeled cells revealed 
no labeled band at the location expected for 13 polypeptides 
(results not shown). Although it is impossible to rule out the 
possibility that the detergents we used disrupted the ot133, 
complex before or during immunoprecipitation, varying the 
nature and concentration of ionic and non-ionic detergents 
failed to produce immunoprecipitates containing 133,. It is 
unlikely that introduction of the epitope sequence into re- 
combinant oes prevented its binding to/3% on two grounds: 
(a) The epitope does not detectably alter ors-mediated sig- 
nal  transduction  or  subcellular  distribution  of HA-oes, as 
shown above; and (b) the functional defect of the G226A mu- 
tant, which is thought to result from its tight attachment to 
133, in membranes (4,  18), is perfectly preserved in HA-ots- 
G226A (Fig. 3, and see below). An alternative possibility is 
that the 12CA5 antibody itself interferes stericaUy with bind- 
ing of/33' to HA-ors; in  an overnight incubation,  12CA5- 
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HA ceils (lane 1 ) or 200/~g HA membranes (lane 2) were extracted 
in  RIPA buffer  and  immunoprecipitated  with  12CA5-coupled 
sepharose beads (see Materials and Methods). Immunoprecipitates 
were subjected to SDS-PAGE,  electroblotted to PVDF membranes, 
and probed with the 12CA5 ascites fluid diluted 1:50 in blotto (50 
mM Tris, pH 7.4,150 mM NaC1, 5% powdered nonfat milk, 0.05% 
Tween-20).  The  probe  was  visualized  with  z25I-labeled goat 
anti-mouse  antibody  (New  England  Nuclear-DuPont,  Boston, 
MA) and autoradiography. Five pmol of a recombinant fragment 
of HA-as was electrophoresed alongside (lane 3), to serve as a 
densitometric  standard for quantitation.  Molecular weight stan- 
dards are seen to the right.  Before loading, the antigen-coupled 
12CA5-Sepharose beads were boiled in reducing buffer, releasing 
both  the  bound  antigen (HA-o~s) and  a  fraction  of the  3' and  K 
chains of the 12CA5 mAb. These chains were thus present on the 
PVDF membranes  and  reacted  with the  ~25I-labeled goat anti- 
mouse antibody (arrows). 
coated beads could compete against/~qr  for binding the a 
subunit. The competition is successful, as shown by the quan- 
titative  immunoprecipitation of HA-as  from cell  extracts 
(Fig. 4 A). 
Turnover of Normal and Mutant c~s 
For turnover studies, cells were labeled for 20 rain by in- 
cubation  with  [3sS]methionine/cysteine  (pulse)  and  then 
divided into fractions for immediate lysis (zero time) or con- 
tinued culture in normal medium containing excess cold me- 
thionine and cysteine (chase).  At appropriate times,  cells 
were harvested and lysed, and the whole-ceU detergent ex- 
tracts  were  subjected  to  immunoprecipitation  and  SDS- 
PAGE (see Materials and Methods). Fig, 6 A shows repre- 
sentative autoradiographs for each cell line tested, and Figs. 
6,  B  and  C depict the time courses of as degradation,  as 
quantitated by liquid scintillation spectroscopy of excised 
bands.  All  cell lines  tested  showed biphasic  decay of as 
radioactivity, with a  very rapid early phase and a  slower, 
mono-exponential second phase. In the first phase, confined 
more or less to the first hour after pulse labeling, radioactive 
as  decreased by 40--45 %;  the kinetics of this  first phase 
were not further analyzed. Analysis of later time points re- 
vealed similar fractional rates of as degradation in HA in 
HAGA cells (0.03 h -t for both). This rate corresponds to a 
half-life of 22 h and indicates that the G226A mutation in the 
a~ of HAGA cells does not accelerate or slow the turnover 
of o,s. In contrast, HA-as-R201C was degraded at a  much 
faster rate (0.11 h -t, half-life 6.2 h); the faster degradation 
may account, at least in part, for the lower amount of o~s de- 
tected in membrane preparations from HARC cells, as com- 
pared to as in membranes of HA and HAGA cells. 
Fig. 6 C shows that cholera toxin treatment increased the 
rate of degradation of HA-as in HA cells. HA-o~cG226A in 
HAGA cells showed a  similar response to the toxin. This 
effect may be responsible for the marked reduction of im- 
munodetectable as in membranes of cells exposed for sev- 
eral hours to cholera toxin, as reported by us (5) and others 
(21).  Indeed, the fractional rate of degradation of HA-~xs in 
toxin-treated cells (0.14  h  -1)  closely approximates that of 
HA-o~cR201C (0.11 h-t); the latter protein contains a  cys- 
teine at position 201  instead of the arginine that is ADP- 
ribosylated in HA-as. Both the covalently modified normal 
protein and the mutant protein hydrolyze GTP at reduced 
rates, relative to unmodified wild type as (7,  17). This sug- 
gests that the increased degradation rate induced by the toxin 
is not caused by ADP-ribosylation per se, but rather by an 
alteration in conformation or function that results from de- 
creased GTPase activity. It is unlikely that the rapid degrada- 
tion is caused by elevated intracellular cAMP, because we 
were unable to detect effects of stimulators of adenylyl cyclase 
(isoproterenol, forskolin) or an inhibitor of cAMP degrada- 
tion (isobutylmethylxanthine) or turnover of as.  These re- 
suits are in keeping with the previously reported (5) failure 
of cAMP analogs or elevated cellular cAMP to lower a, in 
membranes of treated ceils. 
tes Content of  Membrane vs. Soluble Fractions 
Two observations led us to suspect that the R201C mutation 
may increase the relative amount of as in the soluble frac- 
tion of cell extracts. First, the strong signal seen with radio- 
labeled HA-ctcR201C in pulse-chase studies,  using whole 
cell extracts (Fig. 6 A), was not in keeping with the markedly 
reduced amount of HA-as-R201C  in membranes prepared 
from HARC cells, as compared to the amount of HA-a~ in 
HA membranes (Fig. 2 A, lane 3 vs. lane 4); the amount of 
as was 6.3-fold greater in HA than in HARC membranes, 
as  determined  by  densitometry  (Table  I).  Second,  this 
marked decrease in membrane as was not fully accounted 
for by the 3.7-fold greater fractional degradation rate of HA- 
as-R201C  compared to  HA-as  (0.11 vs.  0.03  h -1,  respec- 
tively). 
Fig. 7  shows that the suspicion was correct: subcellular 
fractionation showed that in HARC cells most of the HA- 
as-R201C  is in the soluble fraction. For each of the three 
cell lines  (HA,  HARC,  and HAGA), 4  ￿  107 cells were 
divided into two equal aliquots. One was detergent lysed and 
immunoprecipitated with 12CA5 beads to provide a measure 
of all the as present in the cell. The other aliquot was sus- 
pended in hypotonic (non-detergent) buffer, dounce-homog- 
enized, and centrifuged at 150,000 g. The pellet (P150) was 
extracted in detergent buffer, while the supernatant (S150) 
fraction was adjusted to buffer conditions identical to those 
in the P150 extract (see Materials and Methods). Both S150 
and P150 were then subjected to immunoprecipitation with 
12CA5 antibody, followed by SDS-PAGE, and immunoblot- 
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mal and mutant HA-c~s. Rep- 
resentative  autoradiographs 
are shown  in A, degradation 
curves in B and (7. Cells (2 ￿ 
108  per  experiment)  were 
starved  in  methionine/cys- 
teine-free  medium  for  3  h, 
then  pulse-labeled with  250 
#Ci/rnl  [35S]methionine/cys- 
teine for 20 min. The labeled 
cells  were  washed,  divided 
into  five equal  aliquots,  and 
incubated  in  chase  medium 
(4 ￿  105 cells per ml). At the 
indicated times, the cells were 
lysed and subjected to immu- 
noprecipitation,  SDS-PAGE 
and autoradiography. (A) Au- 
toradiographs of HA, HAGA, 
and HARC pulse-chase  experi- 
ments are shown in rows 1, 2, 
and  3,  respectively. HA and 
HAGA cells were also chased 
in  medium  containing  100 
ng/ml cholera toxin (rows  4 
and  5,  respectively).  Chase 
times were 0 to 36 h for HA 
and HAGA ceils, and 0 to 8 h 
for HARC and cholera toxin- 
treated cells, as indicated. (B) 
Degradation curves for HA-~s, 
HA-c~,-G226A,  and  HA-c~- 
R201C.  (C)  Degradation 
curves for HA-~s and HA-at 
G226A,  in  the presence and 
absence  of  cholera  toxin. 
Curves  were  constructed  as 
follows: bands corresponding to normal or mutant HA-c~ were excised from gels and radioactivity was quantitated by liquid scintillation 
spectroscopy. Degradation was then plotted as percent radioactivity (compared to 100%  at time 0) vs. time. Each time point represents 
the average (+SD) of values obtained from at least three independent pulse-chase experiments. 
ting with a  rabbit anti-o~, antiserum  (Fig.  7).  Both HA-o~, 
and HA-o~,-G220A were located predominantly in the par- 
ticulate fraction, with a small signal in the S150 fraction. In 
contrast, most of the HA=(x,-R201C protein was found in the 
soluble fraction.  Table I  summarizes these results. 
The presence of HA-oe,-R201C in the S150  fraction may 
reflect an  increased relative amount  of this protein in the 
Table L  Cellular Content and Degradation Rates of  Normal 
and Mutant Epitope-tagged ot, in Transfected  Cell Lines 
a, per cell* ' 
Degradation 
Cell line  Whole  cell  P150  S150  rate (h  -E) 
HA  240,000  216,000(90)  24,000(10)  0.03 
HARC  168,000  34,000(20)  134,000(80)  0.11 
HAGA  144,000  108,000(75)  36,000(25)  0.03 
* Numbers represent  the number of c~, molecules  in whole  cells or fractions, 
as quantitateA with the anti-epitope  antibody, using a purified recombinant 
epitope~  fragment of a, as a standard (see Materials and Methods). 
numbers in parentheses represent  the percentage of total oq in the soluble  or 
pellet fractions. 
Figure 7. Distribution of nor- 
real  and  mutant  HA-o~s be- 
tween soluble and particulate 
fractions. For each experiment, 
4  ￿  107  cells  were  divided 
into two equal aliquots. One 
aliquot was  lysed in the de- 
tergent-based  RIPA  buffer 
("whole-cell" extract)  as  de- 
scribed in Materials  and Meth- 
ods.  The  other  aliquot  was 
resuspended in hypotonic (non- 
detergent)  buffer,  dounce- 
homogenized, and centrifuged 
at 150,000 g. The pellet Cpar- 
ticulate') was resuspended in RIPA buffer for detergent extraction, 
while the supernatant ("soluble")  fraction was adjusted with deter- 
gent and NaCI to concentrations equivalent to those in RIPA buffer. 
Thus,  HA-c~  in the particulate and  soluble fractions combined 
should equal that of the whole-cell extract. Samples were subjected 
to immunoprecipitation with 12CAS-coupled sepharose beads and 
SDS-PAGE, blotted and probed with anti-peptide antibody specific 
to c~s. Probes were visualized with 125I-labeled  protein A and auto- 
radiography. 
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pulse-labeled  for 20  min  with  250  #Ci/ml  35S-labeled methio- 
nine/cysteine,  then chased in the presence (+) or absence (-) of 
100 ng/ml cholera toxin.  At the indicated  times,  cells  were har- 
vested, suspended in hypotonic buffer, lysed by dounce homogeni- 
zation, and the soluble  fraction was recovered by centrifuging  the 
lysate for 30 min at 150,000 g. The soluble fractions from each time 
point were then  subjected  to immunoprecipitation with  12CA5- 
coupled sepharose beads and analyzed by SDS-PAGE and autoradi- 
ography.  Arrows mark the position of the cz subunit  in each au- 
toradiograph. 
GTP-bound active form,  caused by the GTPase-inhibiting 
mutation.  Moreover,  cholera  toxin  treatment  in  vitro  is 
reported to induce dissociation of c6 from membranes (19, 
24). Accordingly, we asked whether cholera toxin treatment 
of intact  cells  could elevate  the amount of cz~ in the  S150 
fraction (Fig. 8). Cells were pulse labeled with [35S]methio- 
nine/cysteine and chased in the presence or absence of chol- 
era toxin.  At the times indicated,  cells were lysed and the 
S150 fractions were subjected to immunoprecipitation with 
12CA5  antibody.  At 2  h,  soluble  HA-cts was  significantly 
increased in extracts of toxin-treated HA cells (Fig.  8, lanes 
4  vs.  5  of row  /).  As  expected,  HA-ol~-R201C  was  not 
affected by the toxin, but was instead abundant in the S150 
fraction of HARC cells throughout the chase (Fig. 8, row 2). 
HA-tx,-G226A, however,  was detected in the S150 fraction 
of HAGA cells only immediately following synthesis (Fig. 8, 
0  h  chase,  lane 1  of row 3).  Although cholera toxin ADP- 
ribosylates  cts-G226A (4,  29)  and  accelerates  its  degrada- 
tion (Fig.  6  C),  the toxin does not induce re-entry of HA- 
ots-G226A into the soluble pool. 
Figure 9. Effect of isoprotere- 
nol  on  soluble  HA-ors and 
HA-tx~-G226A.  Ceils  (3  ￿ 
107  per  sample)  were  sus- 
pended in phosphate buffered 
saline in the presence (lanes 2 
and 3) or absence  (lane 1) of 
10  #M  isoproterenol.  The 
effect  of antagonist  was  as- 
sessed by pre-incubating the cells for 120 s with 10 gM propranolol 
before adding isoproterenol  (lane 3). Cells were lysed within two 
min of exposure to isoproterenol  by pelleting,  resuspending  in ice- 
cold hypotonic buffer,  and dounce homogenization.  The soluble 
fractions were recovered by centrifugation  at 150,000 g for 30 min, 
then subjected to immunoprecipitation with 12CA5-coupled  seph- 
arose beads. The immunoprecipitates  were analyzed by SDS-PAGE 
and Western  blotting  as described in Fig.  7. 
Figure  10. Time course of soluble HA-~xs after treatment  with iso- 
proterenol or isoproterenol  followed by propranolol. (A) HA ceils 
(3  ￿  107 per sample) were resuspended  in 1 ml PBS with 10 #M 
isoproterenol  and incubated  at 37~  At the indicated  times,  ceils 
were rapidly pelleted,  resuspended  in ice-cold hypotonic buffer, 
and lysed by dounce homogenization.  Soluble HA-c~s  was isolated 
and analyzed as in Fig. 9. (B) HA cells were resuspended  in PBS 
plus isoproterenol  as in A but after two min,  10 #M propranolol 
was added to each sample.  Cells  were harvested  at the indicated 
times and analyzed as in A). (C) Densitometry was performed on 
the blots  shown in A and B and translated  to a graph. The y-axis 
represents  an  arbitrary  scale  based  on  absorbance.  The  arrow 
marks the time point at which propranolol was added. 
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If an increase in the amount of GTP-bound ot subunit is the 
mechanism by which cholera toxin induces HA-ors to shift 
into the S150 fraction, then isoproterenol, a/3-AR agonist, 
should induce a similar shift. Indeed, just such a shift has 
been reported in $49  (26)  and mouse mastocytoma ceils 
(24).  In our hands, immunoblot analysis of S150 fractions, 
using a  rabbit anti-ors antibody, revealed in wild type $49 
cells a  reproducible increase in soluble cts in response to 
isoproterenol; the effect was difficult to quantitate, however, 
because the maximal amount of S150 protein that can be sub- 
jected to SDS-PAGE contains little as protein. For this rea- 
son, we studied the phenomenon in HA cells, in which the 
pool of HA-as subunits in the S150 fraction is small but 
readily immunoprecipitated and quantitated (see Fig. 7, lane 
3 of row/). 
Exposure of HA cells to isoproterenol for two minutes 
substantially increased HA-o~ in the S150 fraction (Fig. 9); 
the  isoproterenol-induced increase  in  soluble  HA-o~s was 
blocked by prior addition of a/3-AR antagonist, propranolol. 
Densitometry showed that the S150 fraction of unstimulated 
cells contained 10%  of total cellular HA-ct~; immediately 
following stimulation with isoproterenol,  30%  of HA-o~ 
was  found in the  S150  fraction-a threefold increase.  In 
keeping with the functional defect of a~-G226A (4, 18, 30), 
isoproterenol failed to induce movement of HA-acG226A 
into the S150 fraction (Fig. 9). 
Kinetic analysis showed that the  isoproterenol-induced 
shift of HA-ors into the S150 fraction was rapid (maximally 
detectable immediately after addition of the agonist); the 
amount of soluble HA-ot~ declined slowly over the ensuing 
10  min  (Fig.  10  A).  We  deduce  that the  protein  is  not 
degraded, but rather is returned to the particulate fraction, 
because cells treated with isoproterenol did not display ac- 
celerated turnover of HA-as.  Because isoproterenol treat- 
ment elevates soluble HA-or, it should reciprocally reduce 
HA-c~s in the particulate fraction. We could not reproduci- 
bty detect such a decrease (result not shown), probably be- 
cause it is much more difficult to measure the *20%  de- 
crease in the P150 fraction than the ~,300% increase seen 
in the S150 fraction. In contrast to the rapid effect of isopro- 
terenol, cholera toxin produced a maximal increase in solu- 
ble HA-ct~ after a 2-h lag (Fig. 8); the lag is presumably re- 
quired  for  the  toxin  to  penetrate  the  cells  and catalyze 
ADP-ribosylation of ot~. 
To determine the rate of disappearance of HA-ot~ from 
the soluble fraction after cessation of fl-AR stimulation, HA 
cells were treated with isoproterenol (agonist) for 2 min and 
then "chased" with propranolol (Fig.  10 B). Although pro- 
pranolol can be assumed to inhibit/~-AR stimulation very 
rapidly (i.e., in seconds), soluble HA-o~s returned only par- 
tially toward baseline two min after addition of the  an- 
tagonist; complete reversal of the isoproterenol effect re- 
quired more than five rain. 
Fig. 10 C plots time vs. relative absorbance, obtained by 
densitometry of the ~t, bands in Figs. 10, A and B. The tem- 
poral resolution of such an experiment is limited, owing to 
the unavoidable time delay required for %topping" each incu- 
bation (at least 2 min for centrifugation of cells and prepara- 
tion  of a  celt-free  extract  for  immunoprecipitation;  see 
Materials and Methods). Fig. 10 C shows the results of a sin- 
gle experiment. Additional experiments reproduced the ob- 
servations that isoproterenol induces a relatively tong-lived 
increase in soluble oLs, amounting to •20%  of total tx~, and 
that propranolol shifted ot~ back to the membrane fraction. 
Discussion 
We have developed a useful model system for studying the 
behavior of t~s in an intact cell. Addition of an epitope did 
not detectably alter the protein's ability to mediate hormonal 
stimulation of adenylyl cyclase, but did enable us to immu- 
noprecipitate  it  quantitatively from  whole-cell  detergent 
extracts and subcelhlar fractions; such quantitative immu- 
noprecipitation was not feasible with polyclonal anti-as an- 
tibodies available to us. The epitope allowed us to examine 
the behavior of normal and mutant ~s in intact cells. Acti- 
vation of ct~-by  cholera toxin,  mutation, or hormone- 
altered its rate of degradation, membrane avidity, and cellu- 
lar content. 
Activation Accelerates r  Degradation 
Pulse-chase studies revealed that degradation of HA-ors is 
biphasic.  Approximately 40%  of the protein disappeared 
rapidly, within an hour or so; this newly synthesized HA-c~s 
is located exclusively in the soluble fraction of  the cell. After 
transfer to the particulate fraction, the remaining HA-c~s 
decayed at a slow rate (0.03 h  -t, half-life 22 h). The biphasic 
degradation curve suggests that newly synthesized HA-t~ is 
unstable until it associates with the particulate fraction. Such 
behavior is not unusual for proteins targeted to the cytoplas- 
mic face of membranes; glutamic acid decarboxylase (6) and 
o~-spectrin (23)  are  two  such examples.  Protection of ors 
from rapid degradation may result from association with an- 
other  protein  or  proteins,  such  as  the  /3  T  subunit  or  a 
chaperonin.  If abundance of the putative protecting pro- 
tein(s) is limiting, then the size of the rapidly degraded pool 
may be greater for HA-c~s than for endogenous ot~, because 
the promoter in the retroviral vector may induce relative 
overproduction of the recombinant o~s polypeptide. 
Another group has reported (12) that endogenous ot~ in 
$49 cells turns over with a half-life of  42 h, almost twice the 
half-life we found for the more stable (particulate) pool of 
HA-t~. Does the substitution of five amino acids in HA-cts 
cause the protein to turn over more rapidly than does its en- 
dogenous counterpart? We think it more likely that technical 
problems in the earlier experiments (12) account for the dis- 
crepancy.  In those  experiments  the  "pulse" of metabolic 
labeling required incubation for 24 h with radioactive amino 
acid, in contrast to the 20-min pulse used in our experi- 
ments. $49 cells tolerate 20-rain exposure to Tran35Slabel 
very well, as shown by their ability to proliferate at a normal 
rate upon transfer to normal medium; in our hands, how- 
ever,  prolonged  exposure  (that  is,  for  several  hours)  to 
Tran35S1abel causes significant cell death and a decrease in 
subsequent doubling rate. Indeed, in the previous study (12) 
incorporation of radiolabel into ot~ was complete by 8 h of 
the 24-h pulse-a finding that is kinetically incompatible 
with a half-life of  42 h, but consistent with the possibility that 
by 8 h many of the radiolabeled cells had ceased to take up 
nutrients. Thus the 42-h half-life may have reflected behavior 
of cells that were moribund or dead. In addition, the same 
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immunoprecipitate a significant fraction of cellular as. In- 
complete immunoprecipitation may have accounted for the 
weak cts signal in their immunoblots (autoradiographs in 
our experiments required 12-h exposure, vs.  1-4 wk in the 
other study). 
Cholera  toxin  and  the  activating  R201C  mutation  in- 
creased degradation of HA-a, 3.5- to 5-fold and caused the 
a  subunit to move from the particulate to the soluble frac- 
tion. These observations explain the greatly reduced amounts 
of as protein found in membranes of cells treated with chol- 
era toxin (5, 21) and in particulate extracts from human pitu- 
itea~ tumors containing gsp mutations, such as R201C, in the 
as gene (L. Vallar, personal communication). It is possible 
that the acceleration of as degradation represents a physio- 
logically relevant feedback response to activation of the Gs 
signalling pathway. In any case, activation of as, whether by 
mutation or by toxin-catalyzed ADP-ribosylation, promotes 
transfer of a, into a soluble fraction and accelerates its deg- 
radation. It is appealing to infer that the soluble pool of a, 
represents the route of accelerated degradation taken by the 
activated protein. The inference is wrong, however, as shown 
by the  behavior of HA-as-G226A.  The  toxin accelerates 
turnover of HA~s-G226A,  but does not push it into the 
soluble fraction (Fig. 8). 
Activation Alters Membrane Avidity of  re, 
It seems likely that a GTP-induced change in conformation 
of wild type HA-t~, is responsible for both the increase in 
turnover rate and the loosening of its attachment to mem- 
branes. If so, how can the toxin accelerate degradation of 
HA-as-G226A  but fail to stimulate adenylyl cyclase in mem- 
branes of  cells carrying the G226A mutation (Fig. 3; and see 
references 4 and 30)? Indeed, the $49 clone containing the 
as-G226a mutation was isolated by virtue of its inability to 
accumulate cAMP in response to cholera toxin (30). The ap- 
parent discrepancy can be accounted by recognizing that the 
G226A mutation does not absolutely block GTP-induced ac- 
tivation of t~s (18),  but instead prevents GTP-induced dis- 
sociation of arG226A from the/37 subunit (18, 22). Thus, 
recombinant as-G226A,  produced  in E.  coli, binds  and 
hydrolyzes GTP, and mediates GTP-induced stimulation of 
adenylyl cyclase (18), while the same protein expressed in 
an $49 cell cannot stimulate cAMP synthesis, apparently be- 
cause GTP-induced activation cannot pry it loose from bind- 
ing to ~/. Accordingly, the evidence is consistent with the 
idea that a change in the conformation of t~s, induced by 
binding GTP and prolonged by the R201C mutation or by 
toxin-catalyzed ADP-ribosylation, suffices to accelerate deg- 
radation. 
In keeping with the idea that the activated conformation 
reduces avidity with which as binds to the plasma mem- 
brane, isoproterenol, a ~-AR agonist, rapidly (<2 min) in- 
duced a shift of approximately 20% of totai HA-as from the 
particulate to the soluble fraction (Fig.  10). In a previous 
study (26), using different methods for ceil disruption and 
quantitation,  isoproterenol  treatment caused  as  much  as 
50%  of a,  in $49  cells  to become soluble,  with a  time 
course that differed from what we observed. In our experi- 
ments, the isoproterenol-induced increase in soluble HA-as 
declined slowly (perhaps in association with ~-AR desensiti- 
zation);  10 min after addition of propranolol, a BAR an- 
tagonist, soluble HA-as declined to baseline. Because iso- 
proterenol did not accelerate HA-as degradation (result not 
shown), we assume that the soluble HA-as released from 
membrane attachment was not degraded during the course 
of treatment with isoproterenol, with or without proprano- 
1ol.  Thus we infer that the soluble HA-a,  seen after ex- 
posure to isoproterenol reflects continuing cycling of HA-as 
between the soluble pool, which it enters after activation of 
Gs by BARs, and the membrane, to which it returns via a 
pathway not yet identified. The return pathway may require 
deactivation of as (by GTP hydrolysis), although it occurs 
more slowly (over several minutes) than would be expected 
if the rate of return were solely limited by the as GTPase 
reaction, for which the reported k~t is ~4 min  -1 (9, 10, 17). 
Why should activation of as-whether induced by isopro- 
terenol, ADP-ribosylation, or mutation-reduce its apparent 
affinity  for membranes? The most obvious explanation is that 
the B7 subunits of G proteins anchor inactive (GDP-bound) 
as subunits to the plasma membrane (31), and that GTP- 
induced activation simply reduces the affinity of as for ~7. 
In accord with this explanation, neither isoproterenol (Fig. 
9)  nor ADP-ribosylation (Fig.  8)  released HA-a,-G226A 
from the particulate fraction, probably because the G226A 
mutant is unable to dissociate from ~7 (4, 18). We have not 
yet tested this explanation, however, because the 12CA5 anti- 
body does not co-immunoprecipitate B'/with HA-ors, as de- 
scribed in the Results section. 
A  second finding with HA-as-G226A, more difficult to 
explain, is that a larger fraction of HA-acG226A, as com- 
pared to HA-a,, is found in the soluble fraction of unstimu- 
lated cells (25%  vs.  10%; Table I and Fig. 7). Perhaps, in 
addition to causing tight binding of ~'g, the G226A mutation 
partially impairs some (as yet unidentified) process required 
for attaching as (or even asBT) to membranes. 
Quantitation of  o~, 
To understand how G proteins amplify hormonal signals in 
intact ceils, we need precise information regarding the sub- 
cellular location and numbers of receptor and effector mole- 
cules, as well as G protein subunits. Table I summarizes our 
quantification of HA-as, which refines and extends earlier 
studies in $49 cells (1, 25,  26).  In HA-a,-transfected $49 
cyc- cells, we found 16.6 5= 2.0 pmol HA-as per mg mem- 
brane protein and 240,000 HA-a, molecules per cell. These 
values are in excellent agreement with earlier estimates (25) 
for endogenous as in wild type $49 cells; this agreement 
reflects our choice to study an HA-a~-transfected clone in 
which  the  complement of HA-a,  detected with  a  poly- 
clonal anti-a~ antiserum, was similar to that of wild type 
$49 ceils (Fig. 2). Previous studies indicate that wild type 
$49 ceils contain, relative to as, much smaller numbers of 
/~-ARs (15) and adenylyl cyclase molecules (1)-1,200 and 
3,000 per cell, respectively. If these estimates are correct, 
an $49 cell contains 200 as molecules for every/~-AR and 
80 as molecules for every adenylyl cyclase molecule. 
Although others have reported agonist-induced release of 
as from attachment to membranes (24),  the number of ors 
molecules released from membranes of intact cells has not 
previously been precisely quantitated. Our quantitative esti- 
mate shows that hormone treatment activates very many 
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regulating adenylyl eyclase. Figs. 9 and 10 indicate that iso- 
proterenol can induce transfer of ,048,000 HA-ors molecules 
(that is, 20 % of 240,000 per cell) from the particulate to the 
soluble fraction. Thus, each of the 1,200 fl-ARs per cell al- 
tered  the membrane attachment of 40 HA-czs  molecules. 
(This  is  probably an underestimation,  because some of  the 
HA-o~, molecules presumably recycled back to the mem- 
brane, as noted  above.) The  48,000  HA-or, molecules 
released by isopmterenol is 16-fold  greater  than the esti- 
mated number (I)  of adenylyl cyclase  molecules per cell. 
Although we do not know what proportion of  the newly 
soluble  HA-o~,  molecules are  in  the  GTP-bound active  state, 
it need not be very large.  Indeed, if the released HA-u~ 
molecules were evenly  dispersed  throughout  the  cell  (an  un- 
likely  proposition)  they  would reach a concentration  of 80 
nM in  cell  water;  adjacent  to  the  plasma  membrane, the  con- 
ccntration  of  HA-as molecules is  probably much higher.  In 
an in vitro study with purified proteins (10), the concentra- 
tion of active c~ required for half-maximal  stimulation of 
adenylyl  cyclase  was only  3.4  nM-,05 % of the minimal 
concentration of HA-c~s, 80 nM, released by isoproterenol. 
In summary, our calculations indicate that the number of 
HA-or, molecules in HA cells-and,  by inference, the num- 
ber of o~s in wild type $49 cells-considerably  exceeds the 
minimal number that would be required for stoichiometric 
activation  of adenylyl  cyclase.  This  is  in keeping  with  a 
previous  study  (5),  in  which  cholera  toxin-treated  cells 
maintained  maximally  elevated  cellular  cAMP  at  a  time 
when they had lost ,090%  of their complement of ot~. Al- 
though the proportion (20%) of total cellular HA-c~ redis- 
tributed  following  isoproterenol  treatment  is  relatively 
small, the number of ~x, redistributed per receptor is large, 
and their concentration adjacent to the membrane is proba- 
bly quite high. The signaling role of these "solubilized" HA- 
o~ molecules is presently unknown. Specifically,  we do not 
know whether the HA-c~, molecules that stimulate adenylyl 
cyclase belong to the soluble or the particulate-bound pool. 
In addition, the soluble o~ isolated by our cell fractionation 
procedures do not necessarily represent HA-ot~ in the cyto- 
sol;  instead,  the "solubility" of HA-c~  may  simply  reflect 
some change that makes it more easily detached from mem- 
branes during cell  lysis.  This change could reflect altered 
conformation of the protein or a covalent modification; an 
example of the latter is depalmitoylation  of p21"% which 
reduces its avidity for binding to membranes (20).  Further 
studies will resolve these issues. 
The epitope approach, which has proved a sensitive and 
precise tool for assessing metabolism and subcellular distri- 
bution of or,  can readily  be applied to similar  studies of 
other G  proteins.  Epitopes  in a,  B,  or ~r subunits should 
eventually provide tools to tackle an even more difficult set 
of problems, by facilitating detection of protein-protein in- 
teractions responsible for G protein-mediated  signaling  in 
intact cells. Our present efforts are directed toward this end. 
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